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Assessing the Impact of Physician Pain on Motivation to Provide Longitudinal Osteopathic
Manipulative Therapy to Patients and its Correlation to Opioid Prescribing: A Cohort Study

Tyler Braly1, Erin Jefferson, DO2; Brian Henriksen PhD MPH3
Indiana University School of Medicine, 2Fort Wayne Medical Education Program, 3Indiana University School of
Medicine-Fort Wayne, Fort Wayne Medical Education Program

1

Background/Objective: In recent years physician wellness has become a priority. Current well-being initiatives
focus on the emotional and spiritual components of health. However, physical pain and its relationship to
wellbeing and patient care has not been examined. We hypothesized that reductions in resident’s physical pain
would impact their enthusiasm for providing OMT services to patients in need of pain management while also
reducing opioid prescribing. Methods: Both allopathic and osteopathic residents were offered biweekly
osteopathic treatments by board certified osteopathic physicians. Participant pain scores were obtained prior to
each treatment. The osteopathic resident cohort was surveyed regarding their motivation to perform OMT (SIM
Scale). Patient OMT encounters provided by the participants were evaluated by tracking the number of segments,
attempts, OMT modality and BMI were correlated with the participants pain scores. Finally, the opioids prescribed
by all participants was compared to their pain scores. Pearson’s correlation and independent t-tests were used for
this project with an alpha of 0.05 for significance. Results: A correlation was demonstrated between patient BMI
and participants delivering osteopathic treatments (p= .006). This study did not identify any statistically significant
correlations between the regularity of received OMT services and physician physical wellness. Additionally, there
was not a statistically significant correlation between the other data points included in this study. Conclusion:
Patients BMI as a surrogate value for their body habitus did correlate with DO physician pain scores. Longitudinal
OMT did not improve provider pain over time thus supporting OMT use in alleviating acute somatic dysfunction.
Provider pain did not correlate with opioid prescribing habits or frequency of OMT as a pain management option.
There remains a need for physical wellness interventions to improve provider wellness and especially for
providers using OMT on large body habitus patients due to its impact on the providers health.

Predicting Cognitive Decline in Long-COVID Patients: A Demographic and Comorbid Analysis
Using BrainCheck Cognitive Assessment

Camden Bohn, BS1; Jason Li, BS1; Noah Todd, BS1; Jessica Pater, PhD2; Jeanne Carroll, RN3;
Brian Henriksen, PhD, MPH1; Fen-Lei Chang, MD, PhD1,3
1
Indiana University School of Medicine, 2Parkview Health, 3Parkview Health Post-COVID Clinic

Introduction: Coronavirus disease (COVID-19) was declared a global pandemic by the World Health
Organization (WHO) on March 11, 2020. From the onset in early January 2020 until now, we have made
monumental steps toward combatting the deadly virus. Now a subset of individuals is experiencing post-acute
sequelae of COVID-19, more colloquially known as Long-COVID. Research surrounding the long-term
consequences of COVID-19 is now at the height of importance as approximately 25-56% of individuals who were
initially diagnosed with COVID-19 will go on to display new neuropsychiatric symptoms [5]. Mind long
consequences of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection include brain fog,
difficulties with memory, and focusing [3]. The burden of disease is substantial. Approximately 5.8% of individuals
will be diagnosed with new psychiatric illnesses [8]. While many of the symptoms associated with Long-COVID
have been summarized, the cognitive decline that takes place because of COVID-19 infection were quantified in
this study using BrainCheck cognitive assessment. Methods: A retrospective chart review was conducted on
subjects’ data that was included in the Parkview Post-COVID Clinic (PPCC). BrainCheck cognitive assessment
measures were the main cognitive metric utilized to assess cognitive decline in patients. BrainCheck cognitive
assessment compares patient’s current cognitive levels to the national average by using normalizations and
standard deviations. Subcategories of the BrainCheck cognitive assessment include attention, mental flexibility,
executive functioning, and memory. Age, gender, weight, BMI, and hospitalization status were the demographic
and predisposing factors that were analyzed, looking for correlations with levels of cognitive decline experience by
patients. Pearson Correlation Coefficient calculations were conducted on the continuous variables, and PointBiserial Correlation Coefficient calculations were conducted on the dichotomous variables. Furthermore, ANOVA
and chi-squared analysis was done to assess for differences among stratified groups.
Results: There is a correlation between age and mental flexibility (p-value = <.001, correlation = 0.3131),
indicating that with increased age there is a less decline in the mental flexibility aspect of cognitive function. There
is a correlation between age and executive functioning digit symbol substitution (p-value = 0.03431, correlation =

0.1601), indicating that younger individuals will have worse cognitive decline in complex attention and processing
speed. There is also a correlation between age and executive functioning Stroop color interference (p-value =
0.01904, correlation = 0.1661), indicating that younger individuals will experience a worse decline in their
judgement and decision making. There is a correlation between hospitalization status and immediate memory
recognition (p-value = 0.01107, correlation = 0.1742), indicating that being hospitalized at the onset of COVID-19
infection leads to worse short-term memory. Lastly, when stratifying the sample by BMI, the chi-squared analysis
yielded significance (chi-squared = 14.00, p-value = <.001) when comparing to BrainCheck mental flexibility
scores. This would suggest that BMI has implications for differing levels of cognitive decline in Long-COVID
patients. Conclusion: The aim of this study was to utilize the PPCC database to analyze levels of cognitive
decline in Long-COVID patients, looking for correlations between predisposing factors, as well as demographics.
It was determined that age, BMI, and hospitalization status have indications for differing levels of decline in certain
aspects of cognition for patients experiencing Long-COVID symptoms. The goal is to inform clinicians on what
levels of cognitive decline to expect from Long-COVID patients and shed light on COVID-19’s effect on the central
nervous system.

The Use of Anticoagulants in COVID-19 Positive Patients on Extracorporeal Membrane
Oxygenation
Gabriella Cunningham1, John Morton, CCP2; Hannah Copeland, MD FACS FACC2
1
Indiana University School of Medicine-Fort Wayne, 2 Lutheran Health Network

Background: Anticoagulation during extracorporeal membrane oxygenation (ECMO) for COVID-19 patients is
complicated by thromboembolic and bleeding events. The primary objective of the study aims to assess the
incidence of bleeding and thromboembolic events in COVID-19 positive patients treated with ECMO in the
presence or absence of various anticoagulant therapies. Methods: The study included 26 patients in a
retrospective case review of electronic medical records who began ECMO therapy from September 2020 to
January 2022. Patients were positive for COVID-19 infection,18 years or older, and on ECMO for greater than 24
hours. The data was assessed with a standard paired t-test, survival proportions, and Chi-squared analysis.
Results: Patients who received more frequent administration of intravenous anticoagulants had an increased total
bleeding event (p=.004). The data demonstrated an increased risk of mortality associated with increased
bleeding events X2 (25, N=26) = 8.1723, p=.017, but not increased risk of mortality associated with increased
deep venous thromboses X2 (25, N=26) = 1.663, p=.435. Conclusions: Based on this study, treatment guideline
should recommend less frequent anticoagulation therapy to decrease the risk of bleeding events and mortality for
COVID-19 patients on ECMO.

A Mineralized Allograft in Lumbar Interbody Fusion – A Retrospective Chart Review Study
Jay Fiechter1, Micah Smith, MD2
Indiana University School of Medicine, 2Orthopaedics Northeast (ONE)

1

Background: Lumbar interbody fusion is a routine surgical intervention for treatment of degenerative disc
disease to treat lumbar stenosis. Minimally invasive surgical approaches do not afford the opportunity to harvest
large amounts of local bone autograft, therefore iliac crest autograft and or additional allograft material is strongly
relied upon to achieve an arthrodesis. This study uses a blend of a blend of Ventris Medical’s osteoinductive
allograft; Allocell® and SurGenTec’s nanoputty OsteoFlo® as an effective autograft extension material. Methods:
A retrospective chart review was performed on patients that underwent lumbar interbody fusion between October
2021 and January 2022. Demographic information was recorded, three- and six-month follow-up radiographs
were assessed, and arthrodesis was graded using the Bridwell Anterior Grading System. Results: A total of 18
patients were included in the study, representing 27 lumbar level fusions. A Bridwell grade of I (successful fusion)
was achieved at three months in 11.1% of cases and at six months in 85.2% of cases. Four fusions remained a
Bridwell grade of II at six months and were subsequently evaluated for complete arthrodesis. No patients received
a Bridwell grade of IV (lucency with collapse of graft) at three- or six-month follow-up.
Conclusions: The combination of OsteoFlo® and Allocell® contributed to successful arthrodesis status post
lumbar fusion.

Creating a Patient Registry for the Parkview Vein Clinic

Katrina Fliotsos1, Michael GeRue, RN, MSN2; David Sowden, MD3; Carly Daley, PhD2
1
Indiana University School of Medicine; 2Parkview Heart Institute; 3Parkview Physicians Group—Cardiovascular
Surgery
Background/Objective: The Parkview Vein Clinic provides individualized care to patients suffering from venous
disease by providing assessment, education, treatment, ultrasound imaging, and surgical interventions all under
one roof. The Vein Clinic has experienced a consistent increase in patient volume since opening in 2019, creating
a need for tracking patient outcomes. Patient registries are useful tools for tracking high volumes of patients,
assessing outcomes, and improving treatment guidelines. The main objective of this quality improvement project
is to define the workflow for creating a patient registry for the Vein Clinic and determine which data points are
feasible to collect. Methods: This is a retrospective chart review of patients with the diagnosis of “venous stasis
ulcer” seen at the Vein Clinic from September 2019 to July 2022. A total of 84 data fields were collected on each
patient, including information on demographics, medical history, ulcer descriptions, imaging, procedure
information, and post-procedure follow-up. The Society for Venous Surgery Vascular Quality Initiative was used
as a template for registry design, with the goal of merging the registry with the national database in the future.
Results: Venous ulcer information, including number of healed ulcers, duration of ulcer, and largest diameter
active ulcer, was not readily accessible within the chart and required expanded review find and quantify. All other
categories were readily accessible in the chart. Conclusions: The data collected by the registry will be useful for
future quality improvement purposes of the Vein Clinic. Creation of a structured reporting template in Epic would
help facilitate the ease and accuracy of data extraction and help maintain the internal validity of the registry. More
detailed follow-up assessments should be implemented to track patient outcomes, which could include use of the
Venous Clinical Severity Score or a patient-reported outcomes assessment.

Traumatic Brain Injury in a Level II Trauma Center Network Serving Rural Northeastern Indiana:
A Cross-Sectional Study
Isaac Kipfer1, BS; Thein Zhu2, MBBS, FACE, FRCP; Lisa Hollister2, RN, DNP; Dazar Opoku2, MPH
Indiana University School of Medicine1; Parkview Trauma Center2

Background: CDC Report to Congress states that there is a need for research to fill gaps in current Traumatic
Brain Injury (TBI) epidemiology for at risk populations including age groups 0-4, 15-19, and 75+, males, and
residents of rural geographic areas to help understand injury mechanisms, burden, and elucidate preventive
resources. This study aimed to characterize the epidemiological picture of TBI in a level II trauma center network
serving a rural area by measuring TBI incidence, causal factors, and outcomes. Secondarily, patients aged 65
and above (Seniors) have worse outcomes post-TBI; therefore, we sought to determine predictors associated with
post-TBI mortality in the senior population. Methods: A retrospective cross-sectional study of TBI in northeastern
Indiana was conducted with cases selected from 2019 TBI patients from five counties admitted or transferred to
Parkview affiliated hospitals (n=404). Incidence rates (IR) and age-adjusted IR per 1,000 study county residents
was examined by age group and gender. We used descriptive analysis of TBI type, mechanism of injury (MOI),
intent of injury, and hospital transfer by age group and patient type (ED, hospitalization, deaths), and analytical
analysis of mortality post-TBI for seniors (n=120) using multivariable logistic regression. Results: Males (2.5) and
75+ age group (6.7) had the highest IRs per 1,000 residents. Concussions were the most common TBI in all age
groups (87.7% for 15-19) except for seniors which 71.7% were more severe including intracranial bleeds and/or
skull or orbit fractures. Concussion accounted for 57.6% of ED visits, 17% hospitalizations and 0% deaths. Falls
were the most common MOI for all age groups accounting for 88.3% of senior injuries. Motor vehicle accidents
(MVA) and struck by or against object became significant for ages 5-19 (42.6%, p<0.001) and 20-64 (57.2%,
p<0.001) compared to other age groups. Unintentional injuries were the most common intent for all age groups.
Under 5 and seniors had the highest hospital transfer rates. Binary regression results were significant for
anticoagulant therapy, skull, or orbit fracture, severe TBI, CCI, male sex, and age as predictors for senior mortality
post-TBI. Conclusions: Incidence, severity, and mortality matched national high-risk groups including males and
seniors, but morality data was not remarkable for age groups 0-4 and 15-19. Unintentional falls was the most
common MOI indicating the study population would benefit from a fall prevention program focused on seniors.
Pre-existing anticoagulant therapy and skull or orbit fracture on admission were suggested to be predictors for
senior mortality post-TBI, which adds to the current understanding that these factors are associated with higher
risk of TBI progression acutely and higher mortality for in-hospital patients with severe TBI respectively.

Peripheral Neuropathy in Long-COVID Patients: Demographic Distribution and Medical Risk
Factors

Jason Li1, Camden Bohn1, Noah Todd1, Jessica Pater, PhD2; Jeanne Carroll, RN2; Brian Henriksen, PhD1;
Fen-Lei Chang, MD, PhD2
1
Indiana University School of Medicine, Fort Wayne, Indiana, 2Parkview Health, Fort Wayne, Indiana
Objective: A retrospective study was conducted to examine the relationship between long-COVID peripheral
neuropathy and patient demographics and comorbid medical conditions. Materials and Methods: Electronic
health records of 543 patients from the Parkview Post-COVID Clinic were reviewed for their demographic
information, past medical histories, and post-COVID clinic visit summaries. Based on whether patients had
peripheral neuropathy as a post-COVID clinical visit diagnosis and whether they had had a history of neuropathy
prior to COVID infection, the patients were assigned into the new-onset neuropathy group, progressing and nonprogressing neuropathy groups, and non-neuropathy group. Age and BMI were compared among the four groups
using two-sampled t test. Sex, prior COVID hospitalization status, and chronic comorbidities including
hypertension, diabetes, anemia, congestive heart failure, and hypothyroidism were compared using chi-squared
test. Results: 19 of 543 (3.5%) patients had new-onset neuropathy and 18 (3.3%) were found to have
progressing neuropathy. Compared with patients with no neuropathy, patients with new-onset neuropathy were of
older age (p = 0.042), more male (p = 0.022), and more frequently hospitalized for COVID (p = 0.003). Compared
to patients with no neuropathy, patients with progressing neuropathy were of older age (p < 0.001), had more
COVID hospitalization (p = 0.033), diabetes (0.014), hypertension (p < 0.001), and anemia (p = 0.02). No
statistically significant relationship was found between neuropathy and factors not listed above. Conclusion: The
study’s incidence of new-onset peripheral neuropathy in long-COVID patients is higher than indicated in the
current literature. Age and COVID hospitalization were found to be risk factors for both new-onset and
progressing neuropathy. Being male was a risk factor for new-onset neuropathy only, in contrast to current
literature suggesting female predominance in peripheral neuropathy and long-COVID. Diabetes, anemia, and
hypertension were risk factors for both progressing and non-progressing neuropathy but not for new-onset
neuropathy.

Complications in Burn Patients Following Fluid Over-Resuscitation

Leah J. Peipert1, James Kraatz, MD2
1
Indiana University School of Medicine; 2Lutheran Medical Group, Department of Burn Care
Background/Objective: Over-resuscitation of burn patients leads to dangerous edema-related sequelae. The
Parkland formula is commonly used to predict fluid requirements in the 24 hours following burn injury, yet studies
report widely varying resuscitation rates. This study aims to assess fluid resuscitation practices at Lutheran
Hospital and evaluate correlations between resuscitation rates and fluid-overload complications. Methods: A
retrospective chart review assessed fluid resuscitation of 36 adult patients with burns affecting at least 15% total
surface body area (TBSA) between May 2020-May 2022 at Lutheran Hospital. Intravenous fluid rates and urine
output (UO) were recorded for the first 24 hours of each patient’s hospital stay. Complications and mortality were
recorded for the entirety of a patient’s hospital stay. Patients who received volumes exceeding those
recommended by the Parkland formula were placed in the high-volume group whereas patients who received a
lesser volume were placed in the low-volume group. Statistical analyses were performed using Microsoft Excel (𝞪𝞪
= 0.05). Results: The study included 36 patients with an average fluid resuscitation of 4.13 ±2.14 mL/kg/%TBSA
in the first 24 hours following hospital admission. Average UO in the high-volume group (n=14) was 1.33 ±0.76
mL/kg/hr compared to 0.75 ±0.47 mL/kg/hr in the low-volume group (n=22). Fluid complications were more
common in the high-volume group (41.7%) compared to the low-volume group (19.0%), but this difference was
not statistically significant (p=0.230). No difference in mortality was observed (p=1.000).
Conclusion: The high-volume group had an average UO exceeding the recommended range (0.5-1.0 mL/kg/hr)
and experienced greater rates of fluid-overload complications (pulmonary edema, compartment syndromes, etc.).
Due to the small sample size and limited power of this study, the difference in fluid-related complications was not
statistically significant. Clinical Impact and Implications: Physicians should limit fluid volumes exceeding the
Parkland formula when resuscitating burn patients to avoid fluid overload sequelae.

Lutheran Children’s Hospital Neonatal Follow-Up Clinic: Risk of Developmental Delay of Preterm
Neonates as a Function of Gestational Birth Age
Abigail Russell1, Susie Stace, RN,CPN2; Susie Allison Soldner,MD 3
1
Indiana University School of Medicine, 2 Lutheran Hospital NFC, 3 Lutheran Hospital NFC

Background/Objectives: About 1 in 10 babies are born prematurely, a number that increased from previous
years because more resources are available and fertility treatments are effective. Children born prematurely have
a higher risk of developmental delays that are associated physically, socially, linguistically, and
neurodevelopmentally. With these delays being commonly associated with preterm infants, there is the need to
continuously study the longitudinal effects caused by being born prematurely. Our objectives include creating a
more comprehensive care plan, comparing gestational age with developmental delay levels, and noting
correlations between delays and their respective cohort. We hypothesis the more premature the child was born,
the higher the likelihood of developmental delay(s). Methods: Two main tests were used to look for a correlation
between the delay or lack of a delay with the child’s adjusted age. TIMP, Test of Infant Motor Performance, was
used at two different age intervals to measure infant motor capacity. The ASQ, Ages and Stages Questionnaire,
was used to screen several different developmental areas of concern, including social and behavioral abilities.
Results: The data shows the developmental delay decreasing over time in all preterm cohorts with an exception
being the late preterm cohort, likely due to its small sample size. The Chi-square test is not significant for the
TIMP1 and TIMP2 comparisons of preterm cohorts. The ASQ data sets did not have a clear consensus of data.
Conclusions: There is an increase of developmental delay in neonatal infants in comparison to the standard
developmental milestones. A positive finding is that there is an overall decrease in developmental delay as the
child progresses in age. Potential Impact: This research may promote other hospitals to implement a NFC for
patient care and research considerations.

The Effects of the COVID-19 Pandemic on IVC Filter Placement
Dylan Schneider1, Emily Keltner2, T Eric White, MD2
1
Indiana University School of Medicine, 2Parkview Heart Institute

Background: IVC filters are self-expanding stents that have been used to prevent pulmonary embolisms when
anticoagulants are contraindicated. However, the current literature shows no decrease in mortality when using a
filter. These filters can be retrievable or permanent. Retrieval of filters is imperative to their success as prolonged
dwell time can cause further complications. The IVC filter clinic was created in July 2017 to track patient
outcomes and to provide improved care. Objectives: The purpose of this study is to determine differences in
indication, removal rate, follow-up rate, dwell time, mortality, and general trends before and during the COVID-19
pandemic. Methods: The current study is a retrospective chart review of patients who received an IVC filter
between July 2017 and June 2022. In determining differences related to the COVID-19 pandemic, March 2020
was used as the start date of the pandemic, and it is ongoing through June 2022. Results: There was a decrease
in 1 year survival (86% vs 63%, p = .000412) when patients did not receive a follow-up office visit. There was a
decrease in follow-up rate (86% vs 77%, p = .049762) after the onset of the COVID-19 pandemic. Patients who
had their retrievable filter removed were significantly more likely to be alive at 1 year than those who did not get
their filter removed (95% vs 72%, p < .00001). There was no significant change in indication, removal rate, dwell
time, or 1-year mortality after the start of the pandemic. Conclusions and Potential Impact: A patient’s chance
of survival can be increased if they attend a follow-up visit, and if they have their filter removed. This indicates the
need for a more selective process in placing retrievable filters. Additionally, this data could also help clinics
around the country place a stronger emphasis on follow-up rate to improve patient survival.

The Impact of Improving Nutrition Status, Pre-habilitation, Optimization of Cardiac
Hemodynamics Including use of Temporary Mechanical Support When Indicated on the
Reduction of Frailty in Patients Evaluated for Advanced Heart Failure Therapies

Mariah Thomas1, Julie Hunter2, Asim Mohammed, MD2
1
Indiana University School of Medicine; 2Lutheran Hospital

Background: Advanced frailty and age are associated with increased mortality, adverse surgical and transplant
outcomes. Aside from bridge-to-transplant ventricular assist device (VAD) implant, minimal literature exists
regarding reversing frailty. The aim of this study was to assess interventions used by Lutheran Heart Transplant
(HTx) and VAD Program on reducing frailty and the impact on short-term operative outcomes. Methods: A
retrospective chart review of 29 patients evaluated in the Lutheran HTx and VAD program was performed. Data
collected included biomarker and demographic data for June 2020 to present. The study population was analyzed
and then stratified by their modified Fried Frailty Phenotype (mFFP) score. Independent analysis was performed
for HTx and VAD cohorts. Fisher’s exact and t-tests were used to analyze categorical and continuous variables,
respectively (alpha = 0.05). Results: 18 out of 29 patients (62%) were classified as frail at initial assessment.
Significant improvements were observed in bilirubin (p=0.017), creatinine (p=0.001), eGFR (p=0.001), lactic acid
(p=0.002), and prealbumin (p=0.002) for the total study population. Frail patients experienced longer intubation (3
vs 4 days) and hospitalization (20 vs 23 days) times post-HTx. Due to limited sample size, we were unable to
analyze the VAD cohort by mFFP score. Conclusions: Significant improvements were seen in kidney function and
nutrition status as indicated by creatinine, eGFR, and prealbumin data. However, the available data was insufficient
to examine the interventions impact on frailty as described by the Fried Frailty Phenotype. Similar to other studies,
frailty was associated with increased intubation and hospitalization duration post-HTx.

Associations Between Psychiatric Symptoms and Cognitive Impairment in Post-Acute Sequelae
of COVID

Noah Todd, MS, BA,a Jessica Pater, PhD,b Jason Li, BS,a Camden Bohn, BS,a Brian Henriksen, PhD,a
Fen-Lei Chang, MD, PhDa, b
a
Indiana University School of Medicine, bParkview Health Post-COVID Clinic (PPCC)

Introduction: Post-acute sequelae of COVID (PASC) is an emerging postviral syndrome affecting patients who
have recovered from acute COVID infection. Symptoms can affect many different organ systems, including the
CNS. Neuropsychiatric complications are common in PASC, affecting roughly 1 in 3 patients who recover from
COVID. The present study aims to investigate relationships between depressive, anxious, somatic, and general
psychiatric symptom burden and cognitive impairment in PASC. Methods: Patients were recruited from the
Parkview Post-COVID Clinic (PPCC) from April 2021 to March 2022. Patients were deemed eligible if data were
available for both Brief Symptomatic Inventory (BSI) and BrainCheck scores. Eligible patients were divided into
low or normal cognitive function based on BrainCheck guidelines, and differences in psychiatric symptom severity
were assessed via Mann-Whitney U testing. Strength and direction of associations were determined using
Pearson’s correlation coefficient. A smaller subset of patients was analyzed for differences in PASC symptom
severity based on Omicron or Delta infection. Results: Generalized cognitive and mental flexibility complaints
were associated with more severe psychiatric symptom burden in all domains measured by BSI (p = 0.003 and p
= 0.01, respectively). Impaired attention was not related to any psychiatric symptom domain (p > 0.05). Impaired
memory was related to more severe symptom burden in all psychiatric domains except depression (immediate
recall p = 0.015; delayed recall p = 0.015). Conclusion: General cognitive and mental flexibility complaints can
be used to prompt clinical suspicion of concurrent psychiatric symptoms. Complaints regarding attention are not
linked to any psychiatric symptom domain. Complaints regarding memory can also provide impetus for
investigating concurrent psychiatric symptoms, excluding depression. These associations can be used to facilitate
earlier diagnosis and treatment of cognitive impairment and psychiatric illness in the context of PASC.

Therapeutic Effects of Benzoylacetonitrile on Microglia Activation in Multiple Sclerosis

Zixuan (Angela) Zhao1, Ping-Chang Kuo2, Barbara A. Scofield2 and Jui-Hung Jimmy Yen2
1
Indiana University School of Medicine, 2Indiana University School of Medicine, Department of Microbiology and
Immunology
Background: Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS).
Pathogenic T cells, such as Th1 and Th17, infiltrate the CNS, resulting in neuroinflammation, demyelination and

axonal damage. Th1 activates microglia (MG) in the CNS and Th17 acts as a chemokine to recruit immune cells
into the CNS. MG is a resident immune cell in the CNS and its activation is associated with destruction of myelin
and secretion of inflammatory cytokines such as IL-12, IL-23 and IL-1β. IL-12 and IL-23 are important for Th1 and
Th17 differentiation and reactivation, respectively. IL-1β is a key mediator of the inflammatory response.
Benzoylacetonitrile (BTN) has been shown to reduce disease severity in mouse model of MS and reduce Th1 and
Th17 differentiation in vitro. However, the effects of BTN on MG are unknown, and this study was aimed to
investigate the effects of BTN on MG activation in vitro. We hypothesize that BTN can suppress MG activation
and decrease the production of inflammatory cytokines. Methods: Primary MG were pretreated with BTN at
concentration of 200µM or 300µM for 2 hours or with DMSO (vehicle), followed by lipopolysaccharide (LPS)
100ng/ml stimulation for 1.5 or 3 hours. RNA was isolated from MG and mRNA expression levels of IL-12, IL-23,
IL-1β were measured using Q-PCR. Results: Our results showed that BTN suppressed MG activation and
reduced inflammatory cytokine production. The mRNA expression levels of IL-12, IL-23, and IL-1β in LPS and
BTN-treated MG were significantly lower than LPS-treated MG. Conclusion: This study demonstrated that BTN
was able to suppress MG expression of inflammatory cytokines in vitro, suggesting that BTN exhibits
immunomodulatory effects on MG activation in vitro. BTN has a potential to attenuate neuroinflammation in MS
through the reduction of inflammatory cytokines.

